

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $43.63
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 22, 26 |
Daily · Wilder smoothing
| Baird |
| maintain |
| Outperform |
| Outperform |
| Sep 22, 26 | RBC Capital | maintain | Outperform | Outperform |
| Sep 21, 26 | Needham | maintain | Buy | Buy |
| Jul 29, 26 | Baird | maintain | Outperform | Outperform |
| Jul 29, 26 | JP Morgan | maintain | Neutral | Neutral |
| Jul 28, 26 | Piper Sandler | maintain | Overweight | Overweight |
| Jul 20, 26 | Stifel | maintain | Buy | Buy |
| Jul 13, 26 | Needham | maintain | Buy | Buy |
| Jul 2, 26 | Mizuho | maintain | Outperform | Outperform |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 54.48 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 76.90 | Oscillator | Neutral |
| Williams %R (14) | -25.24 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.21 (Hist 0.64) | Oscillator | Buy |
| Average Directional Index (14) | 26.31 (+DI 22.7 / -DI 19.0) | Trend | Strong Buy |
| EMA 20 | 42.39 | MA | Buy |
| SMA 20 | 41.45 | MA | Strong Buy |
| EMA 50 | 43.83 | MA | Sell |
| SMA 50 | 44.49 | MA | Sell |
| SMA 200 | 40.10 | MA | Strong Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 8, 26 | Reed Joshua | officer: SVP, Chief Financial Officer | M-Exempt | 9,164 | — |
| Oct 8, 26 | Reed Joshua | officer: SVP, Chief Financial Officer | M-Exempt | 9,164 | — |
| Oct 8, 26 | Reed Joshua | officer: SVP, Chief Financial Officer | F-InKind | 4,069 @ $40.11 | $163.2K |
| Oct 7, 26 | Whitaker Anne Clem | director | A-Award | 17,998 @ $41.45 | $745.9K |
| Oct 7, 26 | Whitaker Anne Clem | director | A-Award | 7,239 | — |
| Oct 2, 26 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2,034 @ $41.03 | $83.46K |
| Sep 14, 26 | Whitaker Anne Clem | director: | 0 | — | |
| Sep 3, 26 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2,034 @ $48.01 | $97.65K |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Tuesday, November 3, 2026 to discuss the company's third quarter financial results. The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers. A replay of the webca.
[url="]Alkermes plc[/url] (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Tuesday, November 3, 2026 to di
Alkermes (ALKS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 28, 2026 | -0.03 | 0.70 | Beat 2650.1% | $496.0M |
| May 5, 2026 | -0.57 | -0.40 | Beat 29.8% | $392.9M |
| Feb 25, 2026 | 0.43 | 0.34 | Miss -20.9% | $384.5M |
| Oct 28, 2025 | 0.37 | 0.49 | Beat 32.9% | $394.2M |
| Jul 29, 2025 | 0.41 | 0.52 | Beat 26.8% | $390.7M |
| May 1, 2025 | 0.25 | 0.13 | Miss -48.9% | $306.5M |
| 3 | Sep 18, 2026 | 2026-09-18 16:48:25 | View |
| 8-K | Sep 16, 2026 | 2026-09-16 09:12:15 | View |
| 4 | Sep 3, 2026 | 2026-09-03 18:32:44 | View |
| 4 | Sep 1, 2026 | 2026-09-01 19:08:43 | View |
| 4 | Aug 17, 2026 | 2026-08-17 18:53:35 | View |
| 8-K | Aug 12, 2026 | 2026-08-12 09:26:48 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | ALKS | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 108.3x | -11.9x · sector 20.7x | Elevated |
| Forward P/E (FY26E) | -80.5x | EPS est. -0.54 | Discount |
| Price / Book | 4.0x | 3.4x | Elevated |
| Price / Sales | 4.4x | 3.2x | Elevated |
| EV / EBITDA | 38.4x | 24.6x | Elevated |
| Return on equity | 3.7% | — | Weak |
| Gross margin | 84.6% | 83.9% | In line |
| Debt / Equity | 0.87 | 0.23 | Moderate |
| Piotroski / Altman Z | 4/9 | Z 2.18 | Grey zone |
Discounted cash flow model